المؤلفون: Jadoenathmisier KD; Dutch Medicines Evaluation Board, Utrecht, the Netherlands., Stoyanova-Beninska V; Dutch Medicines Evaluation Board, Utrecht, the Netherlands., Soons IM; National IT Institute for Healthcare (Nictiz), the Hague, the Netherlands., Leufkens HG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands. Electronic address: l.t.bloem@uu.nl., Pasmooij AM; Dutch Medicines Evaluation Board, Utrecht, the Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.

المصدر: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2024 Aug 05, pp. 106871. Date of Electronic Publication: 2024 Aug 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science B.V Country of Publication: Netherlands NLM ID: 9317982 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0720 (Electronic) Linking ISSN: 09280987 NLM ISO Abbreviation: Eur J Pharm Sci Subsets: MEDLINE

المؤلفون: Sadreghaemy M; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands., Gamba MA; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands., Egberts TCG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.

المصدر: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Aug; Vol. 33 (8), pp. e5868.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic) Linking ISSN: 10538569 NLM ISO Abbreviation: Pharmacoepidemiol Drug Saf Subsets: MEDLINE

مواضيع طبية MeSH: Amoxicillin*/administration & dosage , Anti-Bacterial Agents*/administration & dosage , Suspensions*, Humans ; Netherlands ; Child, Preschool ; Infant ; Child ; Retrospective Studies ; Female ; Male ; Infant, Newborn ; Practice Patterns, Physicians'/statistics & numerical data ; Cohort Studies ; Pharmacies/statistics & numerical data ; Drug Prescriptions/statistics & numerical data ; Drug Packaging ; Databases, Factual

المؤلفون: Madrid Paredes J; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Versteeg JW; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Vreman RA; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

المصدر: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Jul; Vol. 116 (1), pp. 136-146. Date of Electronic Publication: 2024 Mar 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Technology Assessment, Biomedical*, Humans ; Europe ; Drug Approval ; Health Services Accessibility ; Off-Label Use/statistics & numerical data

المؤلفون: Hogervorst MA; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, the Netherlands., van Hattem CC; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, the Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, University of Amsterdam, Amsterdam, the Netherlands., Mantel-Teeuwisse AK; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, the Netherlands., Goettsch WG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, the Netherlands; National Health Care Institute (ZIN), Diemen, the Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, the Netherlands. Electronic address: l.t.bloem@uu.nl.

المصدر: Drug discovery today [Drug Discov Today] 2024 Jul; Vol. 29 (7), pp. 104031. Date of Electronic Publication: 2024 May 23.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Science Ltd. Country of Publication: England NLM ID: 9604391 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5832 (Electronic) Linking ISSN: 13596446 NLM ISO Abbreviation: Drug Discov Today Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/drug therapy , Benzamides*/therapeutic use , Pyrimidines*/therapeutic use , Pyrimidines*/pharmacology, Humans ; Europe ; Indazoles/therapeutic use ; Pyrazoles/therapeutic use ; Decision Making ; Antineoplastic Agents/therapeutic use ; Antineoplastic Agents/pharmacology ; Clinical Decision-Making ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/pharmacology

المؤلفون: Maksimova MV; Department of Bioethics and Health Humanities, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands., van Thiel GJMW; Department of Bioethics and Health Humanities, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands., Tromp Y; Department of Bioethics and Health Humanities, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands., Lechner R; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, Netherlands., van Delden JJM; Department of Bioethics and Health Humanities, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.

المصدر: Frontiers in medicine [Front Med (Lausanne)] 2024 Jun 24; Vol. 11, pp. 1408553. Date of Electronic Publication: 2024 Jun 24 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE

المؤلفون: Verweij S; Dutch Medicines Evaluation Board, Utrecht, The Netherlands.; Unit of PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, Groningen University, Groningen, The Netherlands., Haverhoek V; Dutch Medicines Evaluation Board, Utrecht, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Bergman E; Swedish Medical Products Agency, Uppsala, Sweden., Westman G; Swedish Medical Products Agency, Uppsala, Sweden.; Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

المصدر: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Apr; Vol. 115 (4), pp. 871-880. Date of Electronic Publication: 2024 Feb 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Natural Language Processing* , Communication*, Humans ; Uncertainty ; European Union

المؤلفون: Verschueren MV; Department of Clinical Pharmacy, St. Antonius Hospital, Utrecht, Nieuwegein, Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands. Electronic address: m.v.verschueren@uu.nl., Peters BJ; Department of Clinical Pharmacy, St. Antonius Hospital, Utrecht, Nieuwegein, Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands., Kruik VR; Department of Clinical Pharmacy, St. Antonius Hospital, Utrecht, Nieuwegein, Netherlands., Uitvlugt EB; Department of Clinical Pharmacy, OLVG, Amsterdam, Netherlands., Bijsmans AR; Department of Pulmonology, Maasstad Hospital, Rotterdam, Netherlands., Egberts AC; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, Netherlands., van de Garde EM; Department of Clinical Pharmacy, St. Antonius Hospital, Utrecht, Nieuwegein, Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.

المصدر: Clinical lung cancer [Clin Lung Cancer] 2024 Mar; Vol. 25 (2), pp. 119-127.e1. Date of Electronic Publication: 2023 Dec 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/pathology , Carcinoma, Squamous Cell*/drug therapy , Antibodies, Monoclonal, Humanized*, Humans ; B7-H1 Antigen/metabolism ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use

المؤلفون: Brinkhuis F; Division of pharmacoepidemiology and clinical pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands., Goettsch WG; Division of pharmacoepidemiology and clinical pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.; National Health Care Institute, Diemen, Netherlands., Mantel-Teeuwisse AK; Division of pharmacoepidemiology and clinical pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands., Bloem LT; Division of pharmacoepidemiology and clinical pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.

المصدر: BMJ (Clinical research ed.) [BMJ] 2024 Feb 29; Vol. 384, pp. q511. Date of Electronic Publication: 2024 Feb 29.

نوع المنشور: Editorial

بيانات الدورية: Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-1833 (Electronic) Linking ISSN: 09598138 NLM ISO Abbreviation: BMJ Subsets: MEDLINE

مواضيع طبية MeSH: Medical Oncology* , Drug Costs*, Humans ; Cost-Benefit Analysis

المؤلفون: Brinkhuis F; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Goettsch WG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; National Health Care Institute, Diemen, The Netherlands., Mantel-Teeuwisse AK; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

المصدر: BMJ (Clinical research ed.) [BMJ] 2024 Feb 28; Vol. 384, pp. e077391. Date of Electronic Publication: 2024 Feb 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-1833 (Electronic) Linking ISSN: 09598138 NLM ISO Abbreviation: BMJ Subsets: MEDLINE

مواضيع طبية MeSH: Drug Approval* , Neoplasms*/drug therapy, Humans ; United States ; Retrospective Studies ; Germany ; Medical Oncology ; France

المؤلفون: van den Berg RB, Laarman ARC, Bloem LT, Dijkstra JA, Veldkamp AI, Allegaert K, Swart EL, van Weissenbruch MM

المصدر: International journal of clinical pharmacology and therapeutics [Int J Clin Pharmacol Ther] 2023 Aug; Vol. 61 (8), pp. 354-362.

نوع المنشور: Observational Study; Journal Article

بيانات الدورية: Publisher: Dustri-Verlag Dr. K. Feistle Country of Publication: Germany NLM ID: 9423309 Publication Model: Print Cited Medium: Print ISSN: 0946-1965 (Print) Linking ISSN: 09461965 NLM ISO Abbreviation: Int J Clin Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Acetaminophen* , Pain*/prevention & control, Infant, Newborn ; Humans ; Administration, Intravenous ; Retrospective Studies ; Anti-Bacterial Agents/therapeutic use